Session 18
The digital transformation of healthcare in Europe
Challenges and opportunities for the European medicines regulatory network
Thursday, 26 September 2024 | 12:15-13:30 | Kursaal
Organised by the European Medicines Agency
The European medicines regulatory network (EMRN) has already made plans to ensure the digital transformation of the regulatory health space over the next ten years. The “Data Analysis and Real World Interrogation Network” (DARWIN EU), a federated network established by the European Medicines Agency (EMA) and EMRN, delivers real-world evidence from across Europe on diseases, populations and the uses and performance of medicines. It is in its third year of onboarding data partners and supporting the regulatory network with data analytics, and is paving the way for the European Health Data Space (EHDS). Partners of the EMRN are preparing for increased use of Artificial Intelligence and machine learning during all phases of medicines development while undergoing digital transformation themselves.
Join us for this session to debate with key stakeholders how Europe is putting data and digital at the heart of its future activities. Share your views on the critical success factors that are needed to unlock the full digital potential of EMRN. Discuss the challenges and opportunities in working together to achieve the digital transformation of healthcare in Europe.
SPEAKERS
- Nikolai Brun, Chief Medical Officer, Affibody AB
- Zaïde Frias, Head of Digital Business Transformation Task Force, European Medicines Agency
- Rosa Giuliani, Member of European Policy Committee, European Society for Medical Oncology
- Marco Marsella, Director, Digital, EU4Health and Health Systems Modernisation, European Commission Directorate-General for Health and Food Safety
- Peter Rijnbeek, Professor of Medical Informatics, Erasmus MC
MODERATOR
- Steffen Thirstrup, Chief Medical Officer, European Medicines Agency
